Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

C.M. Huijts, S.J.A.M. Santegoets, A.J.M. van den Eertwegh, L.S. Pijpers, J.B. Haanen, T.D. de Gruijl, H.M.W. Verheul, J.J. van der Vliet

Research output: Contribution to journalArticleAcademicpeer-review

89 Downloads (Pure)
Original languageUndefined/Unknown
Article number505
JournalBMC Cancer
Publication statusPublished - 2011

Cite this